Technicals for NATCO Pharma Limited
The Tripple MOVING AVG is currently neutral, showing no clear bias toward...
The Tripple MOVING AVG is currently neutral, showing no clear bias toward...
NATCO Pharma Limited's Forward PE is in a strong range, indicating that...
The list of all important regulatory filings for NATCO Pharma Limited which...
An analysis of JPMorgan Chase's $105 billion 2026 expense guidance, exploring its...
An investor-oriented article synthesising corporate leaders’ optimism for 2025 and the top...
An investor-focused analysis of major shifts in the financial services landscape as...
| Published | Title | Summary |
|---|---|---|
| 2025-07-25 17:06:34 | Acquisition-XBRL | NATCO PHARMA LIMITED has informed the Exchange regarding Acquisition... |
| 2025-01-30 16:38:38 | Board Meeting Intimation | NATCO PHARMA LIMITED has informed the Exchange about Board Meeting... |
| 2024-08-12 14:07:44 | Dividend | Natco Pharma Limited has informed the Exchange that Board of... |
| 2024-07-26 16:06:49 | Board Meeting Intimation | NATCO PHARMA LIMITED has informed the Exchange about Board Meeting... |
Lists of companies in NSE500 with the best and the worst fundamentals...
List of the latest important filings for NSE500....
Lists of companies in NSE500 with the best and the worst technicals...
An article analysing how new U.S. tariff policies are contributing to economic...
An article exploring Oracle’s latest quarterly results that reveal a significant AI...
An in-depth article analysing the Federal Reserve’s December 2025 rate cut and...